ORIC Pharmaceuticals (NASDAQ: ORIC) net income
ORIC Pharmaceuticals reported a net loss of $129.5m for fiscal 2025; in fiscal 2024 it reported a net loss of $127.8m. Earnings per share were −$1.47.
ORIC Pharmaceuticals's best year of the last 7 was fiscal 2019. It reported a loss in 7 of those 7 years.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Net income by fiscal year
| Fiscal year | Net income | Change | Net margin | Earnings per share |
|---|---|---|---|---|
| 2025 | −$129.5m | — | — | −$1.47 |
| 2024 | −$127.8m | — | — | −$1.83 |
| 2023 | −$100.7m | — | — | −$1.96 |
| 2022 | −$89.1m | — | — | −$2.25 |
| 2021 | −$78.7m | — | — | −$2.07 |
| 2020 | −$73.7m | — | — | — |
| 2019 | −$26.9m | — | — | — |
The change compares each fiscal year with the one before and is not calculated when the previous year closed with a loss. Net margin is net income over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
ORIC Pharmaceuticals net income compared with its sector
By net income for its latest fiscal year, ORIC Pharmaceuticals ranks 362nd of the 501 US health care companies with a page on Celsmar.
| Rank | Company | Net income | Net margin |
|---|---|---|---|
| 360th | Erasca | −$124.5m | — |
| 361st | Jade Biosciences | −$127.4m | — |
| 362nd | ORIC Pharmaceuticals | −$129.5m | — |
| 363rd | Protagonist Therapeutics | −$130.1m | −282.8% |
| 364th | Cartesian Therapeutics | −$130.3m | −4,658.6% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the net income of ORIC Pharmaceuticals
- How much did ORIC Pharmaceuticals earn in fiscal 2025?
- ORIC Pharmaceuticals reported a net loss of $129.5m for fiscal 2025. In fiscal 2024 it reported a net loss of $127.8m.
- What are the earnings per share of ORIC Pharmaceuticals?
- They were −$1.47 in fiscal 2025, compared with −$1.83 in fiscal 2024.
- Where does ORIC Pharmaceuticals rank in its sector by net income?
- It ranks 362nd of the 501 US health care companies with a page on Celsmar, by net income for its latest fiscal year.
- Where do the figures for ORIC Pharmaceuticals come from?
- From the annual report (Form 10-K) that ORIC Pharmaceuticals files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that ORIC Pharmaceuticals files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019. More on ORIC Pharmaceuticals: the ORIC Pharmaceuticals page · annual accounts · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.